Search results

• 2018

  Results of a placebo-controlled double blind randomised trial to investigate the efficacy of rifaximin-alpha versus placebo in improving systemic inflammation in patients with cirrhosis and chronic hepatic encephalopathy (RIFSYS Trial)

  Patel, V., Mcphail, M. J. W., Zamalloa, A., Stoy, S., Vijay, G. M., Huang, X., Rogers, G., Choo, J., Edwards, L., Gray, E., Woodhouse, C., Gencer, S., Coen, M., Wendon, J., Bruce, K. & Shawcross, D., Apr 2018, In: Journal of Hepatology. 68, p. S107-S108

  Research output: Contribution to journal › Meeting Abstract › peer-review